Alectinib is a prescription medication used to treat a certain type of advanced lung cancer. Alectinib belongs to a group of drugs called kinase inhibitors. These work by blocking the activity of the ALK (gene mutation) protein to prevent cancer cells from growing and spreading.

This medication comes in capsule (by mouth) form and is taken twice a day with food.

Common side effects of alectinib include tiredness, constipation, and swelling in the hands, feet, ankles, and eyelids.


Dinutuximab is a prescription medication used to treat high-risk neuroblastoma, a rare type of cancer that affects infants and young children. Dinutuximab is a monoclonal antibody that works by using the immune system to target and destroy tumor cells.

Dinutuximab comes in a liquid to be given by intravenous (IV) injection over a period of 10 to 20 hours for 4 days in a row. It may be given for up to 5 cycles.


Obinutuzumab is a prescription medication used to treat patients with chronic lymphocytic leukemia (CLL) or follicular lymphoma. Obinutuzumab belongs to a group of drugs called monoclonal antibodies. These work by helping the body slow or stop the growth of cancer cells.

This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional.

Common side effects of obinutuzumab include infusion reactions, fever, and cough.